Patents by Inventor Scott M. Belcher

Scott M. Belcher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220308064
    Abstract: Disclosed herein are compositions and methods for characterizing protein binding to per-and polyfluoroalkyl substances (PFAS).
    Type: Application
    Filed: March 25, 2022
    Publication date: September 29, 2022
    Inventors: Scott M. Belcher, Thomas W. Jackson
  • Patent number: 6506576
    Abstract: The invention is a system for maintenance and high-throughput analysis of cerebellar granule neurons in tissue culture plates under chemically defined conditions. The invention includes serum-free granule culture medium, which is composed of high glucose Dulbecco's Modified Eagle Media (DMEM), NaHCO3, sodium pyruvate, and HEPES, which is subsequently adjusted to pH 7.2. The HEPES buffered DMEM is then supplemented with L-glutamine, KCl, bovine albumin, insulin, transferrin, selenium, penicillin, and streptomycin. Unlike proprietary neuronal culture media, this invention does not include any serum, steroid hormones, phenol red, or added anti-oxidants. The serum-free granule culture medium is then placed in conventional poly-lysine coated tissue culture plates in order to conduct subsequent assays. The invention also includes the ability to package the complete neuronal culture system into a “kit” for isolation, maintenance, treatment, and analysis of cerebellar neurons.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: January 14, 2003
    Inventor: Scott M. Belcher
  • Publication number: 20020132345
    Abstract: The invention is a system for maintenance and high-throughput analysis of cerebellar granule neurons in tissue culture plates under chemically defined conditions. The invention includes serum-free granule culture medium, which is composed of high glucose Dulbecco's Modified Eagle Media (DMEM), NaHCO3, sodium pyruvate, and HEPES, which is subsequently adjusted to pH 7.2. The HEPES buffered DMEM is then supplemented with L-glutamine, KCl, bovine albumin, insulin, transferrin, selenium, penicillin, and streptomycin. Unlike proprietary neuronal culture media, this invention does not include any serum, steroid hormones, phenol red, or added anti-oxidants. The serum-free granule culture medium is then placed in conventional poly-lysine coated tissue culture plates in order to conduct subsequent assays. The invention also includes the ability to package the complete neuronal culture system into a “kit” for isolation, maintenance, treatment, and analysis of cerebellar neurons.
    Type: Application
    Filed: August 9, 2001
    Publication date: September 19, 2002
    Applicant: Board of Trustees of the University of Arkansas
    Inventor: Scott M. Belcher